About Us

Who We Are

Partnering with leading pharmaceutical companies, advanced therapy organizations, universities, hospitals, and government agencies, our team of experts drives innovation in technical operations and manufacturing to support the advancement of groundbreaking therapies for patients in need.

 

FOOTPRINT, TEAM & CULTURE

A Global Network for Global Impact

Our corporate headquarters is located in Shelton, CT. We provide regional support across the United States and are currently supporting projects globally in the EU and APAC.

Our Team

At Project Farma, we invest in full-time employees, not temporary staff or 1099 contractors. This strategy has built a dedicated and skilled team that forms the backbone of our organization. We take pride in our exceptionally low employee turnover rate.

Our Culture

We foster a collaborative environment that encourages teamwork, creativity, and shared success among our team and clients. This approach allows us to overcome challenges and deliver exceptional results. Our team is known for its supportive, inclusive atmosphere that values people and maintains a patient-centered mindset.

Patient-Focused Project Delivery

Our name, Project Farma (PF), reminds us that the Patient comes First. By focusing on philanthropy and keeping patients at the heart of everything we do, we create a culture driven to provide solutions, meet deadlines, and deliver meaningful outcomes.

Philanthropy

Philanthropy is Built
into our Foundation

As a patient-focused delivery team, we are committed to connecting our team members to patients and their families. Connecting our team to the patients has fostered a culture within our organization that is focused on providing solutions, meeting deadlines and getting results.

Learn More
PF Team

Leadership Team

Anshul Mangal

Anshul Mangal

President of Pharma Specialty Services

Anshul Mangal

President of Pharma Specialty Services

Anshul Mangal is the President of Pharma Specialty Services at PerkinElmer, a global consultancy with 2000+ professionals advancing science, manufacturing and digital for life-changing therapies.  He is also the founder of Project Farma and advisor and board member of various life science organizations.   

Anshul founded and steered PF to become a global consulting firm providing manufacturing, automation, IT solutions for complex biologics and novel therapies with 500+ professionals. Under Anshul’s guidance, PF pioneered the industrialization of groundbreaking therapeutics, including the first-ever commercially approved cell and gene, radioligand, and RNA-based therapies, GLP-1s and more cutting-edge biologics. Additionally, Anshul led M&A for PF, bolstering its ability to offer comprehensive solutions to drug developers facing manufacturing challenges.  In 2020, PF was acquired by Blackstone backed Precision Medicine Group (PMG) and, in 2025, acquired by New Mountain Capital backed PerkinElmer, expanding PerkinElmer’s OneSource services platform and appointing Anshul as President of Pharma Specialty Services.

Anshul’s commitment to life sciences extends past PerkinElmer to other for-profit and philanthropic organizations, including LLR Partners, IQHQ, Alliance for Regenerative Medicines, Alliance for mRNA Medicines, Institute for Life Changing Medicines and more.  Earlier in his career, Anshul practiced as a patent litigator and holds degrees in engineering and law. 

Rich Tree

Rich Tree

President

Rich Tree

President

Rich Tree serves as President of Project Farma, where he oversees firm-wide delivery, operational performance, and strategic initiatives supporting growth across the biopharmaceutical and advanced manufacturing industry. In this role, he is responsible for aligning regional and practice-area teams to ensure consistent execution, client satisfaction, and scalable delivery across Project Farma’s portfolio.

Rich brings extensive experience across life sciences operations, engineering, and regulated manufacturing environments, having led global teams through complex capital programs, operational transformations, and high-impact delivery initiatives supporting pharmaceuticals, biologics, and advanced therapies.

He is a United States Navy veteran and holds a Doctorate in Engineering Management, a Master of Business Administration, and has completed executive education programs at Stanford University and Harvard University. He is known for his disciplined leadership approach, emphasis on operational rigor, and commitment to building high-performing teams in complex, highly regulated environments.

Adam Pfeiffer

Adam Pfeiffer

SVP, Commercial Excellence

Adam Pfeiffer

SVP, Commercial Excellence

Adam Pfeiffer is a SVP, Commercial Excellence at Project Farma with over 20 years of life sciences consulting experience. In his role, he leads firm-wide business strategy and collaborates closely with operations, marketing, and business development teams to expand Project Farma’s global partnerships across the biopharmaceutical sector. 

Adam has supported numerous drug manufacturers in bringing life-saving therapies to market, with deep expertise in engineering, commissioning and qualification, and GMP compliance for advanced therapies and large-molecule biologics. His experience spans clinical and commercial manufacturing, where he has played a critical role in delivering complex capital projects that support the development and delivery of cutting-edge treatments. Adam holds a degree in Chemical Engineering from Colorado State University.

Anthony Wickline

Anthony Wickline

VP, Finance

Anthony Wickline

VP, Finance

Anthony Wickline serves as Vice President of Finance at Project Farma, where he leads financial planning, analysis, and business intelligence to support strategic growth and operational decision-making across the organization. In this role, Anthony partners with leadership and project teams to translate financial data into actionable insights that optimize resources and advance delivery for clients in highly regulated life sciences environments.

With expertise in budgeting, forecasting, and financial strategy, Anthony plays a key role in enabling Project Farma’s ability to scale responsibly while supporting the execution of complex programs that advance life-saving therapies. He is known for his collaborative, solutions-oriented approach and his ability to make financial information clear and accessible for cross-functional leaders.

Anthony is a Certified Public Accountant (CPA) and brings a strong foundation in accounting and business management, holding a Bachelor of Science in Accounting and Business Management from George Mason University.

Greg Gara

Greg Gara

Chief Technical Officer

Greg Gara

Chief Technical Officer

Greg Gara serves as Chief Technical Officer at Project Farma, where he leads technical strategy across advanced manufacturing and supports clients through the full lifecycle of facility development, from design and construction through startup and regulatory licensure.

With more than 30 years of global biotechnology experience, Greg specializes in gene therapy and advanced manufacturing operations, bringing deep expertise in translating complex technical requirements into practical execution across regulated environments. His leadership experience spans TechOps/CMC functions, including manufacturing, engineering, quality, and program management, at both site and global levels.

Greg holds a degree in Biology and Environmental Science from Augustana College and continues to contribute to the advanced therapies space through operational and technical leadership.

Jim Watson

Jim Watson

Chief Solutions Officer

Jim Watson

Chief Solutions Officer

Jim Watson serves as Chief Solutions Officer at Project Farma, where he leads capital project leadership, operational readiness, and the delivery of GMP-compliant facilities for advanced therapies, biologics, and large-molecule manufacturing. In this role, Jim partners across technical, engineering, and regulatory stakeholders to define and execute strategic solutions that support client readiness and long-term manufacturing success.

With more than 25 years of experience in the pharmaceutical and biotechnology industries, Jim has led initiatives across the full project lifecycle—including early-phase manufacturing strategy, conceptual and detailed design, facility buildout, commissioning, qualification, validation, and facility turnover. His expertise spans high-purity utility systems, complex infrastructure, and cross-functional program leadership, guiding clients through technical and regulatory complexities to bring novel therapies to market.

Jim holds a Bachelor of Science in Chemical Engineering with Biomedical Interests from Worcester Polytechnic Institute and is currently completing his MBA through the University of Central Oklahoma, reflecting his commitment to both technical depth and strategic leadership.

Joseph Neroni

Joseph Neroni

Regional VP, Central

Joseph Neroni

Regional VP, Central

Joe Neroni serves as Regional Vice President for the Central region at Project Farma, where he leads cross-functional delivery teams supporting biologics, advanced therapies, medical device, and aerospace programs. In this role, Joe is responsible for execution oversight, client partnership, and delivery performance across complex, regulated environments.

Joe brings more than a decade of experience leading and supporting large-scale capital programs exceeding $230 million, with expertise spanning program and project management, turnkey facility builds, automation, validation, and engineering. His experience covers the full project lifecycle—from conceptual design and implementation through commissioning and qualification—across upstream, downstream, and fill-finish manufacturing processes.

Throughout his career, Joe has worked with early-stage startups, CMOs, CROs, and commercial manufacturers, serving in roles including Project Manager, Engineering Technical Lead, and CQV Lead. He has also provided strategic advisement in technical operations, facility remediation, and business strategy, and has supported the buildout of gene therapy facilities for some of the first commercially approved therapies. Joe brings a deep technical background and execution-focused leadership approach to every engagement in highly regulated environments.

Sarah Stoll

Sarah Stoll

Regional VP, West

Sarah Stoll

Regional VP, West

Sarah Stoll serves as Regional Vice President for the West region at Project Farma, where she leads delivery and operational strategy across pharmaceutical, biotechnology, and gene therapy programs. In this role, Sarah oversees complex capital initiatives and partners closely with clients to drive execution across highly regulated environments.

Sarah brings more than 10 years of experience in capital project delivery, operational strategy, and program execution, with expertise spanning the full project lifecycle—from project initiation and funding requests through design, construction, commissioning and qualification, validation, and closeout. She is experienced in leading cross-functional teams and managing complex, multi-stakeholder programs that require tight alignment across technical, operational, and governance functions.

A proven leader, Sarah is known for building high-performing teams and delivering strategic outcomes in fast-paced environments. She brings a hands-on, execution-focused approach to complex challenges, providing clear direction and technical oversight from conceptual design through final delivery, while ensuring alignment with client priorities at every phase.

Thomas Struble

Thomas Struble

Regional VP, New England

Thomas Struble

Regional VP, New England

Tom Struble serves as Regional Vice President for the New England region at Project Farma. In this role, Tom partners with biopharmaceutical organizations to design and execute compliant, efficient validation programs that support facility startup, operational readiness, and sustained manufacturing performance.

Tom brings more than 22 years of experience across engineering, facilities management, commissioning, and validation. He is a recognized subject matter expert in CQV, with deep expertise in risk-based validation methodologies, electronic validation platforms, and programs spanning facility startups, utilities commissioning, equipment validation, and electronic validation systems implementation, including KNEAT.

Tom is a former U.S. Navy officer and holds a Bachelor of Science in Geological Engineering from Cornell University and a Master’s degree in Engineering Management from Old Dominion University. He is an active leader within the International Society for Pharmaceutical Engineering (ISPE), having served on the Boston Chapter Board of Directors and continuing to contribute to CQV guidance and industry training initiatives.

Brian Winstead

Brian Winstead

Regional VP, Southeast

Brian Winstead

Regional VP, Southeast

Brian Winstead serves as Regional Vice President for the Southeast region at Project Farma, where he leads delivery teams and oversees client partnerships across one of the firm’s key growth markets. In this role, Brian draws on more than 30 years of experience in industrial and life sciences to drive operational excellence and project success for clients throughout the region.

Brian has managed teams and capital projects ranging from $10K to over $1 billion, working across the country in operations leadership roles that span the full spectrum of pharmaceutical manufacturing. His experience covers solid oral dose, biologics, fill-finish, gene and cell therapy, and controlled substances — giving him a uniquely broad foundation to support clients at every stage of development and commercialization.

A longtime admirer of Project Farma, Brian had worked alongside PF teams on several of his own projects over the years and was consistently impressed by the caliber of the individuals and their dedication to patients. When the opportunity to join arose, he didn’t hesitate. Brian holds a Bachelor of Science in Mechanical Engineering from North Carolina State University. Outside of work, he is an amateur bourbon collector and enjoys life with his wife of 20 years.

Grace Mark

Grace Mark

Regional VP, Mid-Atlantic

Grace Mark

Regional VP, Mid-Atlantic

Grace Mark serves as Regional Vice President of our Mid-Atlantic region at Project Farma. Based in the Washington, D.C. area, Grace supports biopharmaceutical and cell therapy clients across quality, validation, and operational initiatives in regulated environments. In this role, Grace partners with cross-functional teams to deliver high-impact programs that support compliant manufacturing operations.

Grace brings more than 13 years of experience across quality control, validation, operations management, and team leadership. Her career includes impactful roles at CAI, Leidos Biomedical, and Lonza, where she supported and led high-visibility commissioning, qualification, and validation initiatives across complex manufacturing programs.

She holds a Bachelor of Science in Biology from Cedar Crest College, where she completed extensive independent research culminating in a defended thesis on bacteriophage and E. coli interactions in simulated burn victims. Grace also serves as Education Chair for the ISPE Chesapeake Bay Chapter, where she develops educational content and events that strengthen industry engagement and technical knowledge across the regional biotech community.

Evan Bryant

Evan Bryant

Market Director, DC, Maryland & Virginia

Evan Bryant

Market Director, DC, Maryland & Virginia

Evan Bryant serves as Market Director for the DC, Maryland, and Virginia (DMV) market at Project Farma, where he supports clients across regulated manufacturing environments through hands-on technical leadership and execution support. In this role, Evan partners closely with production and engineering teams to drive operational performance and project delivery.

Evan brings several years of experience supporting high-volume manufacturing operations, consistently meeting production targets while advancing safety, quality, and process control objectives. He has a strong track record of providing hands-on technical support to production teams and driving continuous process improvement within regulated environments.

His background includes extensive experience in GMP manufacturing, technical writing, and the development of Standard Operating Procedures. Evan has also supported capital renovation projects involving equipment and utility system specification, procurement, testing, qualification, vendor management, and the oversight of preventative and corrective maintenance programs. He holds a Bachelor of Science in Mechanical Engineering from Michigan State University.

Joe Kenar

Joe Kenar

Market Director, Chicago

Joe Kenar

Market Director, Chicago

Joe Kenar serves as Market Director for the Chicago market at Project Farma, where he supports clients through technical manufacturing solutions, operational readiness, and validation-driven program delivery. In this role, Joe partners with clients to execute complex programs across regulated manufacturing environments.

Joe has been a cornerstone of Project Farma for more than five years, progressing through roles of increasing responsibility and contributing to a wide range of client engagements across the Chicago, Boston, and Philadelphia markets. He is recognized for his leadership, technical aptitude, and strong commitment to Project Farma’s culture and client success.

His background spans engineering, commissioning and qualification, and program management, with hands-on experience supporting major aseptic filling line projects, utility qualifications, instrumentation initiatives, and large-scale facility expansions. Joe brings an execution-focused approach to delivering high-quality outcomes in highly regulated environments.

Sean Terrett

Sean Terrett

Market Director, Philadelphia

Sean Terrett

Market Director, Philadelphia

Sean Terrett is the Market Director for the Philadelphia market at Project Farma, bringing over nine years of experience in technical operations, validation, and strategic leadership within the pharmaceutical, biotech, and gene and cell therapy sectors. Prior to his current role, he served as Senior Manager and Technical Operations Strategy Lead, advising startups and major players on business case analysis, manufacturing strategy, site selection, and capital and operational planning. Sean has led complex tech transfers, facility builds, and validation programs across biologics, CMOs, and advanced therapy organizations, providing expertise in process development, automation, and regulatory compliance.

In his current role, Sean focuses on supporting gene and cell therapy organizations in the Philadelphia region, helping them safely bring transformative therapies to patients. He combines deep operational experience with strategic insight to guide clients through the end-to-end drug development and commercialization process.

Sean holds a Bachelor of Science in Chemical Engineering from Iowa State University.

Allison Cacciatore

Allison Cacciatore

Principal Consultant, Technical Operations

Allison Cacciatore

Principal Consultant, Technical Operations

Allison Cacciatore serves as Vice President of Technical Operations at Project Farma, where she leads manufacturing operations and capital project execution across cGMP-regulated pharmaceutical environments. In this role, Allison partners with clients to ensure facility and equipment readiness, operational reliability, and regulatory compliance across complex manufacturing programs.

Allison brings more than 20 years of experience in pharmaceutical manufacturing and operations, with deep expertise in facility and equipment readiness, regulatory inspections, and large-scale capital project execution. She has served as the primary interface with global health authorities and has led multimillion-dollar capital initiatives supporting both new construction and renovation of cGMP facilities.

She holds a Bachelor of Science in Chemical Engineering and an MBA in Management from Lehigh University and brings a hands-on, execution-focused approach to supporting compliant manufacturing operations.

Brian Cooper

Brian Cooper

Principal Consultant, Technical Operations

Brian Cooper

Principal Consultant, Technical Operations

Brian Cooper serves as Vice President of Technical Operations at Project Farma, where he provides technical leadership across facility design and construction, process engineering, capital project delivery, validation, and technical operations. In this role, Brian supports clients through complex manufacturing challenges spanning early development through commercial operations.

Brian brings more than 30 years of leadership experience across the pharmaceutical and biotechnology industries. His background includes overseeing large-scale capital projects, leading commercial process transfers for biologics, and directing site leadership initiatives across capital planning, quality governance, environmental health and safety, and digitization. He has built and scaled technical operations organizations and led technology transfer and scale-up programs for complex biologics.

Brian holds a Bachelor of Arts in Biochemistry from the University of Colorado at Boulder. In addition to his industry leadership, he serves as a faculty member at California State University, Channel Islands, teaching in the M.S. Biotechnology/MBA program, and is active in the life sciences community as a member of the Board of the Ventura County Industry Council.

Cory Proctor

Cory Proctor

Principal Consultant, Technical Operations

Cory Proctor

Principal Consultant, Technical Operations

Cory Proctor serves as Vice President of Technical Operations at Project Farma, where he leads capital projects, medical device initiatives, and validation programs across the pharmaceutical, biotechnology, and gene therapy industries. In this role, Cory partners with cross-functional teams to deliver complex programs across regulated environments.

Cory brings more than a decade of experience managing projects across the full lifecycle, including project initiation, funding strategy, business case development, conceptual and detailed design, construction, commissioning and qualification, validation, and project closeout. He has successfully led complex, cross-functional teams through high-impact initiatives requiring close alignment across technical, operational, and organizational stakeholders.

His expertise spans both early-phase and late-stage programs, supporting successful execution in fast-paced, regulated settings. Cory is recognized for aligning technical solutions with broader organizational objectives and delivering consistent outcomes across complex project environments.

 

Adrienne Ruddle

Adrienne Ruddle

Principal Consultant, Technical Operations

Adrienne Ruddle

Principal Consultant, Technical Operations

Adrienne Ruddle is a Vice President of Technical Operations at Project Farma. She specializes in aseptic fill-finish, capital projects, validation, external manufacturing, quality systems, and operational excellence. Adrienne blends technical expertise with client partnership and business leadership, making her a trusted advisor to life science organizations.

Prior to joining Project Farma, Adrienne held senior leadership roles at Verista (formerly Clarke Solutions) as Director and Lead Client Partner, managing multi-site client portfolios, expanding strategic partnerships, and delivering complex engineering and validation programs in highly regulated environments. She also supported external manufacturing and quality operations at Sanofi and Hospira, providing GMP oversight for CMOs, managing regulatory inspections, and supporting clinical through commercial products. Her hands-on experience spans validation strategy, risk management, investigations, and continuous improvement initiatives.

Adrienne holds dual Bachelor of Science degrees in Human Nutrition and Kinesiology from Kansas State University and is recognized for her collaborative leadership and operational rigor.

Greg Sears

Greg Sears

Principal Consultant, Technical Operations

Greg Sears

Principal Consultant, Technical Operations

Greg Sears is a Vice President of Vice President of Technical Operations at Project Farma. With more than 29 years of experience across CDMO, consulting, and sponsor environments, Greg brings deep expertise in technical operations, MSAT, CQV, process validation, and commercialization, with a proven track record of successfully commercializing more than 36 processes and supporting products through licensure and market approval.

Greg has led large, multidisciplinary teams supporting aseptic manufacturing across a range of advanced modalities, including viral vectors, gene therapies, and emerging platforms. His experience spans technology transfer from preclinical through commercial production, development of robust validation strategies, and delivery of on-time readiness for new product introductions. He is highly experienced in regulatory engagement and has supported successful approvals across global health authorities.

Throughout his career, Greg has been recognized for his technical rigor, collaborative leadership style, and ability to deliver compliant, scalable manufacturing solutions that protect patient supply. He holds a B.S. in Chemical Engineering with a minor in Chemistry and is passionate about building strong teams and driving operational excellence.

Vicente Ventura

Vicente Ventura

Principal Consultant, Technical Services

Vicente Ventura

Principal Consultant, Technical Services

Vicente Ventura is a Vice President of Technical Services at Project Farma. Bringing over 30 years of experience delivering complex capital projects across parenteral manufacturing, mRNA therapeutics, and medical device development, he has led multibillion-dollar greenfield and brownfield projects from front-end planning through commissioning, qualification, and operational readiness, consistently driving on-time, high-quality delivery.

Vicente has directed global engineering programs, overseeing technical services, maintenance, and manufacturing technology to support cGMP operations and strategic growth. He has successfully unified technical functions, enhanced production throughput, and strengthened regulatory readiness across multiple sites. His leadership spans the design, construction, and operational launch of critical facilities, including vaccine, drug product, and device manufacturing operations worldwide.

He holds a Master’s degree in Mechanical Engineering (Manufacturing Systems Engineering) and a Bachelor’s degree in Mechanical Engineering. Fluent in English and Spanish, Vicente brings extensive international experience across North America, Europe, Asia, and Latin America.

Brian Maschino

Brian Maschino

Principal Consultant, Manufacturing Solutions

Brian Maschino

Principal Consultant, Manufacturing Solutions

Brian Maschino serves as Vice President of Manufacturing Solutions at Project Farma, where he leads engineering and operational initiatives supporting complex, highly regulated manufacturing environments. In this role, Brian partners with clients to advance manufacturing performance through technical execution and operational strategy.

Brian brings more than 20 years of experience in pharmaceutical process engineering, capital project management, and facility operations. His background includes leading large-scale engineering organizations, overseeing multimillion-dollar capital portfolios, and driving site-wide operational transformations across regulated manufacturing sites.

As Vice President of Manufacturing Solutions, Brian applies deep expertise in process design, facility validation, maintenance and reliability, automation, and continuous improvement frameworks to support Project Farma’s mission of enabling reliable, scalable manufacturing operations. He is a licensed Professional Engineer and holds a Bachelor of Science in Chemical Engineering from Rose-Hulman Institute of Technology.

Thomas Hecmanczuk

Thomas Hecmanczuk

Principal Consultant, Manufacturing Solutions

Thomas Hecmanczuk

Principal Consultant, Manufacturing Solutions

Thomas Hecmanczuk is a Vice President of Manufacturing Solutions at Project Farma, based in Charlottesville, Virginia, bringing over 30 years of experience leading complex capital projects across the pharmaceutical, energy, and renewable energy sectors. He specializes in large-scale development, construction, commissioning, and qualification initiatives, providing strategic leadership from early planning through project execution and startup.

Prior to joining Project Farma, Tom served as a Project Consultant supporting Merck & Co.’s Virginia, North Carolina, and New Jersey locations, overseeing projects ranging from $10M to $130M, including vaccine and therapeutic development facilities, electrical infrastructure upgrades, integrated logistics centers, and major utility projects. He also held the role of Vice President of Construction at CCI INGENCO Distributed Energy and spent over 17 years at Merck & Co. in senior project management and facilities leadership positions.

Tom is PMP trained, a U.S. Navy veteran, and holds a Bachelor of Science in Aerospace Engineering from North Carolina State University. His leadership and operational expertise enhance Project Farma’s ability to deliver critical capital and manufacturing solutions.

Nishit Jain

Nishit Jain

Principal Consultant, Process Solutions

Nishit Jain

Principal Consultant, Process Solutions

Nish Jain serves as Vice President of Process Solutions at Project Farma, based in Research Triangle Park, North Carolina, where he leads process development and manufacturing strategy initiatives across multiple biopharmaceutical modalities. In this role, Nish partners with clients to advance process robustness, scalability, and operational readiness within regulated manufacturing environments.

Nish brings more than 18 years of experience in biopharmaceutical manufacturing and technical operations, with deep expertise in technology transfer, process validation, process development, MSAT, and GMP operations. His background includes leading cross-functional efforts in CDMO management for drug substance and drug product manufacturing, upstream process development, and CMC strategy across clinical and commercial programs.

He is a proven leader in process optimization and analytics, applying design of experiments (DOE), continued process verification (CPV), and statistical analysis to drive efficiency and quality. His experience also includes single-use technology platforms, FMEA analysis, and technical investigations. Nish holds a Bachelor of Science in Biomedical Engineering from the Georgia Institute of Technology and an MBA in Strategic Management from Hood College.

Joel Gates

Joel Gates

Principal Consultant, Quality Operations

Joel Gates

Principal Consultant, Quality Operations

Joel Gates serves as Vice President of Quality Operations at Project Farma, based in the Raleigh–Durham, North Carolina area, where he leads quality, validation, and compliance initiatives across global pharmaceutical and biotechnology operations. In this role, Joel partners with clients to strengthen quality systems, support regulatory readiness, and enable compliant manufacturing operations in highly regulated environments.

Joel brings more than 20 years of experience across quality, validation, and compliance leadership, with expertise spanning sterile manufacturing, quality risk management, inspection readiness, and technical operations. He has led enterprise-wide initiatives focused on GMP compliance, audit preparedness, and continuous improvement, serving as a trusted partner to organizations navigating complex regulatory and operational challenges.

He holds a Bachelor’s degree in Biology from the University of Tennessee at Chattanooga and has completed graduate coursework in Strategic Leadership at Middle Tennessee State University. Joel is recognized for his practical, execution-focused approach to building and sustaining effective quality systems across diverse manufacturing environments.

Matthew Snyder

Matthew Snyder

Principal Consultant, Technical Operations

Matthew Snyder

Principal Consultant, Technical Operations

Matthew Snyder is a Vice President of Technical Operations at Project Farma, based in the Philadelphia market, bringing extensive experience in biopharmaceutical engineering, capital project delivery, and facilities and infrastructure leadership. He specializes in GMP manufacturing environments, supporting facility design, construction, commissioning, and lifecycle management to ensure compliant and reliable operations.

Prior to joining Project Farma, Matthew served as Director of Engineering where he led a multidisciplinary team managing capital projects, manufacturing systems, environmental monitoring, and commissioning activities for ATMP operations. He also supported biopharmaceutical and advanced therapy clients as a Senior Project Manager at CRB, overseeing design, construction, and on-site project execution while contributing to business development. Earlier, he spent over a decade at GlaxoSmithKline managing a $15M annual capital portfolio, establishing a project management office, and leading sustainability and operational improvement initiatives.

Matthew holds a Bachelor of Science in Chemical Engineering from Drexel University and is a PMP-certified Lean Six Sigma Green Belt. His expertise in capital project execution and GMP facility operations strengthens Project Farma’s ability to deliver complex manufacturing solutions.

Michael Mietzner

Michael Mietzner

Principal Consultant, Process Operations

Michael Mietzner

Principal Consultant, Process Operations

Michael Mietzner is a Vice President of Process Operations at Project Farma, based in Greater Boston, bringing over 25 years of experience in the biotech and pharmaceutical industries. He specializes in biopharmaceutical engineering, process development, capital project delivery, and cGMP manufacturing across discovery, clinical, and commercial production. Michael has led complex projects spanning facility design, validation, technology transfer, and operational optimization, delivering transformative solutions for clients across vaccines, microbiome therapeutics, and advanced biologics.

Prior to joining Project Farma, Michael founded and led Bio Innoveering LLC, providing technical strategy and project leadership for biopharma clients, and held senior engineering roles where he executed large-scale capital projects, facility upgrades, and process improvements. He has also served on the Scientific Advisory Board for PAK BioSolutions and contributed as a technical consultant across multiple innovative biomanufacturing platforms.

Michael holds a Bachelor of Science in Chemical Engineering from the University of Massachusetts Lowell and is recognized for his expertise in building high-performing technical teams, driving operational excellence, and supporting industry innovation.

Ryan Guerriero

Ryan Guerriero

Principal Consultant, Technical Operations

Ryan Guerriero

Principal Consultant, Technical Operations

Ryan Guerriero is a Vice President of Technical Operations at Project Farma, based in California, bringing over 25 years of experience in engineering, operations, and program management across the life sciences industry. He specializes in process and facilities engineering, capital project delivery, digital transformation, and operational excellence within regulated manufacturing environments. Ryan has led complex initiatives spanning facility design, technical transfer, validation, and infrastructure optimization, supporting clinical and commercial manufacturing operations.

Prior to joining Project Farma, Ryan served as Director and Head of Engineering where he led engineering, facilities, and capital projects for clinical operations and drove sustainability initiatives that significantly reduced energy consumption. He also held global leadership roles where he developed digital transformation strategies across business units.

Ryan holds a Bachelor of Science, MBA, and Master of Science in Pharmaceutical Engineering and is a certified PMP and Lean Six Sigma Black Belt.

Armen Nahabedian

Armen Nahabedian

Principal Consultant, Technical Operations

Armen Nahabedian

Principal Consultant, Technical Operations

Armen Nahabedian is a Vice President of Technical Operations at Project Farma, based in New Hampshire, bringing more than 40 years of experience in biotechnology and pharmaceutical manufacturing. He brings a deep understanding of the science, systems, and scale required to deliver life-changing therapies. He specializes in biotech protein manufacturing, tech transfer, tech services, equipment, cleaning, and validation.

Prior to joining Project Farma, Armen’s background included contributing to innovative efforts beyond core development, and work on bioreactor systems for international partners that helped advance mammalian cell culture and recombinant DNA technology to produce therapeutic proteins. He held multiple leadership roles at large-scale manufacturing facilities, including Validation Manager/Director and Senior Manager of Technical Services. In these roles, he focused on driving operational excellence, ensuring regulatory compliance, and supporting the commercialization of complex biologic therapies. Armen holds a Bachelor of Science, in Chemical Engineering from Northeastern University in Boston.

Thomas Woods

Thomas Woods

Principal Consultant, Technical Operations

Thomas Woods

Principal Consultant, Technical Operations

Thomas Woods serves as Vice President of Technical Operations at Project Farma, based in Alabama, where he leads capital project delivery, commissioning and qualification, engineering operations, and manufacturing startup across the pharmaceutical and life sciences industries. In this role, Tom partners with cross-functional teams to drive complex programs from concept through commercial operation in highly regulated environments.

Tom brings more than 30 years of engineering leadership experience to Project Farma. Prior to joining, he served as Director of Engineering Services at Catalent Consumer Health, where he oversaw engineering, qualification, maintenance, facilities, packaging, and EHS functions for a nutraceutical manufacturing site. While there, he implemented risk-based qualification strategies and drove operational improvements while maintaining regulatory compliance. He has also held senior engineering leadership roles at Griffin Facility Solutions, TriRx Pharmaceutical Services, Par Pharmaceuticals, CSL Behring, and JHP Pharmaceuticals, leading capital programs valued at up to $100 million annually and directing large cross-functional engineering and CQV teams.

Throughout his career, Tom has successfully delivered greenfield and brownfield projects spanning manufacturing expansions, facility startups, and process optimization initiatives in support of GMP operations. He holds a Bachelor of Electrical Engineering from the University of Dayton and has completed MBA coursework at the University of Pittsburgh. Tom is also certified in Lean Six Sigma Green Belt and Kepner-Tregoe Project Management.

Paula Rokosny

Paula Rokosny

Project Controls

Paula Rokosny

Project Controls

Paula Rokosny serves as Vice President of Project Controls at Project Farma, where she leads project controls strategy and execution across complex, regulated programs. In this role, Paula partners with delivery and client teams to establish clear governance, cost and schedule controls, and reporting frameworks that enable effective decision-making across the full project lifecycle.

Paula brings more than 20 years of experience in business operations and project controls, with a track record of building high-performing teams and translating strategic objectives into scalable processes and data-driven decision-making. She developed and implemented a Risk Rating System that categorizes projects by complexity and risk exposure, embedding it into IPS’s reporting and governance framework to improve visibility across the organization. Paula also led the expansion of the company’s Monthly Project Status Review program from 8 to 25 projects, strengthening portfolio-level oversight and accountability.

Earlier in her career at IPS, Paula led the enterprise rollout of a project health management software platform, achieving full adoption across cross-functional teams within six months, and managed a project controls group supporting a portfolio exceeding $900M. She began her career at Lockwood Greene, where she helped build the company’s earned value management system and supported a project portfolio in the pharmaceutical industry. Paula is a recipient of the IPS 2023 Pursuit of Excellence Award and is recognized for her strategic planning, risk mitigation, and client relationship management skills.

Roger Ouimet

Roger Ouimet

Project Management Office

Roger Ouimet

Project Management Office

Roger Ouimet serves as Vice President of Project Management at Project Farma, where he leads project delivery strategy and execution across high-reliability, mission-critical, and regulated environments. In this role, Roger partners with clients and internal teams to drive operational readiness across people, processes, and product, supporting complex programs within pharmaceuticals and advanced manufacturing.

Roger brings more than three decades of leadership experience spanning pharmaceutical and biotech manufacturing, lean operations, and global program management, with project scopes ranging from $55K to $350M. He has led change management, product launches, and expansion capital projects from initial scope and budget approval through execution, and is known for building high-performing, cross-functional teams that turn strategy into results. At CAI, Roger served as Global Director of Program and Project Management, leading a team of six Principal Consultants and Associate Directors and co-authoring the CAI Operational Readiness Playbook, whose global rollout contributed to a 7% increase in company profit. Earlier, at Xellia Pharmaceuticals, he built the site’s Project Management Office and led the Operational Readiness Workstream for a new aseptic filling line through construction, commissioning, qualification, and validation.

Roger’s career also spans global roles at Novo Nordisk, where he managed thirty indirect reports and coached more than 150 personnel across continuous improvement and waste reduction initiatives, and a distinguished career as a Surface Warfare Officer in the U.S. Navy, where he directed the operation and planning of NATO Aircraft Carrier Battle Groups comprising more than 25 ships and 18,000 sailors. He holds an M.S. in Project Management and Operations from Southern New Hampshire University and a B.S. in Chemistry from the U.S. Naval Academy, and is a Certified Program Management Professional (PgMP) and Certified Project Manager through Kepner-Tregoe.

Joe O'Brien

Joe O'Brien

Digital Transformation & Automation

Joe O'Brien

Digital Transformation & Automation

Joe O’Brien serves as Vice President of Digital Transformation and Automation at Project Farma, where he leads digital, automation, and engineering initiatives supporting complex manufacturing environments across the life sciences. In this role, Joe partners with clients to modernize manufacturing operations, improve delivery quality, and reduce capital spend through scalable digital and automation strategies.

Joe brings more than 25 years of experience across digital systems, automation, and engineering leadership within the biotechnology, gene therapy, and pharmaceutical industries. His background includes supporting single-use, multiproduct biotech facilities, gene therapy manufacturing sites, filling lines, and large-scale brownfield redevelopments, with a focus on integrating automation and digital capabilities across the full project lifecycle.

Prior to joining Project Farma, Joe held senior leadership roles at Spark Therapeutics and Pfizer Global Engineering, where he led GMP engineering operations, global automation strategy, digital transformation initiatives, OT cybersecurity programs, and data integrity efforts across global manufacturing networks. He holds a Master’s degree in Engineering Management and a Bachelor’s degree in Electrical and Electronic Engineering from University College Dublin.

George Skillin

George Skillin

Strategy Services

George Skillin

Strategy Services

George Skillin serves as Vice President of Strategy Services at Project Farma, where he leads client partnerships and supports strategic initiatives across the pharmaceutical and biotechnology industries. In this role, George works closely with clients to guide complex capital programs and long-term manufacturing strategies in regulated environments.

George brings more than 30 years of leadership experience spanning engineering, capital program delivery, and global operations. His background includes directing multi-billion-dollar budgets and leading large-scale capital programs, including the design and delivery of state-of-the-art pharmaceutical and biotechnology manufacturing facilities.

He holds an MBA in Finance and Corporate Accounting from the University of Rochester Simon School of Business and a Bachelor of Science in Chemical Engineering from the University of Maine. George is also active in the industry community, having served as a Director for the Boston Chapter of the International Society for Pharmaceutical Engineering (ISPE).

Eric Pittman

Eric Pittman

Quality Assurance & Regulatory Affairs

Eric Pittman

Quality Assurance & Regulatory Affairs

Eric Pittman is a Vice President of Quality and Regulatory Affairs at Project Farma, bringing over 27 years of leadership experience across regulatory compliance, inspection readiness, and global quality systems. He specializes in developing and executing regulatory strategies, preparing organizations for health authority inspections, and building scalable quality frameworks across pharmaceuticals, biologics, and medical devices. Eric has led global inspection readiness efforts across more than 25 sites, supporting teams through complex regulatory interactions and driving consistent, compliant operations.

Prior to joining Project Farma, Eric held senior leadership roles in both industry and federal regulatory agencies, where he directed large teams responsible for inspections, investigations, and compliance programs spanning clinical, non-clinical, and pharmacovigilance activities. He has also contributed to regulatory policy development, international collaboration initiatives, and industry training programs.

Eric holds a Bachelor of Science from Purdue University and a Master of Business Administration from Youngstown State University and is recognized for his ability to align quality, compliance, and business strategy.

Parish McKenzie

Parish McKenzie

Manufacturing & Tech Ops

Parish McKenzie

Manufacturing & Tech Ops

Parish McKenzie is a Vice President of Manufacturing & Tech Ops at Project Farma, bringing nearly three decades of experience in biological and pharmaceutical manufacturing. He specializes in manufacturing operations, continuous improvement, validation, and regulatory compliance, with deep expertise in Six Sigma and Lean methodologies for both day-to-day problem solving and long-term production strategy. Throughout his career, Parish has successfully navigated audits by major regulatory agencies worldwide, including the FDA, EMA, NMPA, and health authorities across Japan, Brazil, Mexico, Canada, Taiwan, and others.

Prior to joining Project Farma, Parish held progressive leadership roles across some of the industry’s most respected organizations. He began his career in chemical manufacturing before joining Baxter Healthcare, where he worked across quality, validation, and manufacturing at a high-speed IV solutions site producing over 1.5 million units per day. He then moved to Baxter’s BioScience division, through its transitions to Baxalta, Shire, and ultimately Takeda, focusing on continuous improvement and manufacturing operations. Subsequent roles at NantKwest in cell therapy clinical manufacturing, CSL in plasma-based therapies, and Grifols, where he served as Vice President of Manufacturing, further shaped his breadth across the biological goods spectrum.

Parish joined Project Farma with a longstanding familiarity with the firm from his time at CSL, drawn by its strong reputation and the opportunity to help build out the organization to better serve the market. He holds a Bachelor of Science in Chemical Engineering from North Carolina State University. A North Carolina native, Parish is a certified scuba diver and avid outdoorsman who enjoys hiking, kayaking, skiing, and exploring new corners of the world.

Nareg Badalian

Nareg Badalian

Reliability & Asset Management

Nareg Badalian

Reliability & Asset Management

Nareg Badalian is a Vice President of Reliability & Asset Management at Project Farma, bringing over 25 years of engineering expertise spanning forensic analysis, pharmaceutical manufacturing, and maintenance and reliability leadership. A licensed Professional Engineer in the state of California, Nareg combines a rigorous analytical foundation with deep operational experience to help life sciences organizations build more resilient, efficient asset management programs.

Nareg began his career at a forensic engineering consulting laboratory, where he spent 12 years conducting failure analysis on product defects, accident reconstruction, and materials and metallurgical analysis. He then transitioned to pharmaceutical manufacturing, joining Baxter Healthcare (later Takeda) where he spent 14 years leading the Maintenance and Reliability organization at a major manufacturing facility. In that role, he developed and executed strategies that drove equipment performance, regulatory compliance, and operational continuity across a complex, high-volume production environment.

Nareg joined Project Farma drawn by the opportunity to make a broader impact. He was drawn to the idea of helping multiple life sciences companies improve their operations and, ultimately, patient access to critical therapies. He holds a degree in Mechanical Engineering and is a licensed PE. Outside of work, he is a well-traveled father of three who has lived on four continents.

Hazem Eleskandarani

Hazem Eleskandarani

VP, Validation

Hazem Eleskandarani

VP, Validation

Hazem Eleskandarani is a Vice President of Validation at Project Farma, bringing more than 30 years of leadership experience in project and process engineering, commissioning, qualification and validation (CQV), engineering quality, and capital program management across the pharmaceutical and biopharmaceutical industries. A licensed Professional Engineer (PE) and certified Project Management Professional (PMP), Hazem has led complex global capital programs and directed cross-functional, multicultural teams through every phase of the project lifecycle — from conceptual design through construction, qualification, and operational readiness.

Hazem began his pharmaceutical career with Fluor Daniel and later Jacobs Engineering, supporting large-scale strategic capital projects as part of the Process Equipment Group. In 2000, he joined Merck as a Project Process Engineer, where he led the end-to-end GMP engineering aspects of major capital initiatives. He then joined Johnson & Johnson in 2014 as Global Head of Commissioning and Qualification, establishing and leading the company’s C&Q Center of Excellence and driving strategy, governance, and execution across J&J’s global GMP capital project portfolio. Most recently, he served four years at CSL Behring as Global Head of Engineering Quality, providing global oversight for quality assurance, risk management, and execution excellence across capital and operational engineering programs.

Beyond his industry roles, Hazem is an active member of the ISPE Commissioning & Qualification Community of Practice Steering Committee, a former Chair of the organization, and a co-author of the latest edition of the ISPE Baseline® Guide Volume 5: Risk-Based Commissioning and Qualification. He joined Project Farma to contribute to the industry in a broader, more impactful way — working alongside recognized subject matter experts to help clients achieve excellence in engineering and regulatory compliance. Hazem holds a B.Sc. and Master’s degree in Mechanical Engineering from the University of Alexandria and the University of Utah, respectively, and completed an Executive Leadership Program at Cornell University. Born and raised in Alexandria, Egypt, he is an avid traveler and the proudly appointed favorite person of his dog, Cleopatra.

Ellen Venezia

Ellen Venezia

Client Engagement, Northeast

Ellen Venezia

Client Engagement, Northeast

Ellen Venezia serves as Vice President of Client Engagement for the Northeast region at Project Farma, where she leads client partnerships and engagement strategy across the life sciences sector. In this role, Ellen works closely with clients to support complex programs and long-term initiatives spanning regulated manufacturing and capital project delivery.

Ellen brings more than 30 years of experience in life sciences, with a career equally rooted in process engineering and business development. A lifelong New Jersey resident, she has played a key role in advancing the regional life sciences community, cultivating trusted, long-term client relationships, and leading major capital project portfolios across the New Jersey, Pennsylvania, and Delaware corridor and beyond.

She is an active industry leader and serves as Vice President of Membership for the ISPE Delaware Valley Chapter. Ellen holds a Bachelor of Science in Chemical Engineering from Rutgers University and brings a strong blend of technical depth and commercial insight to supporting clients across the Northeast region.

Jim Rice

Jim Rice

Client Engagement, West

Jim Rice

Client Engagement, West

Jim Rice serves as Vice President, Client Engagement for the Western region at Project Farma, bringing over 30 years of leadership in engineering, facilities, and capital program management across the pharmaceutical, biotechnology, and advanced therapy sectors. He captures top performance throughout the design, construction, startup, and continuous improvement of manufacturing operations focused on delivering key business objectives and product supply to patients.

Jim holds an MBA from Northeastern University, a B.S. in Mechanical Engineering from Worcester Polytechnic Institute, and additional degrees in Business Administration and Civil Engineering.

Sigmund Aarø

Sigmund Aarø

Client Engagement, South

Sigmund Aarø

Client Engagement, South

SIgmund Aarø is a Vice President of Client Engagement for the Southern region at Project Farma, bringing over 25 years of experience in industrial and manufacturing sectors with a focus on life sciences, chemicals, and food and beverage industries. He specializes in factory and process automation, operational excellence, and leveraging cutting-edge technologies to optimize processes, improve quality, and enhance safety.

Sigmund has a proven track record in driving profitable growth, developing strategic partnerships, executing M&A transactions, and delivering value to clients and stakeholders. His career spans Europe and North America, where he has managed global accounts, led cross-functional teams, and executed complex projects across diverse markets. He has also founded and sold a software and hardware company and holds a patent, reflecting his combined technical and business expertise.

Sigmund is passionate about integrating engineering, business, and digital solutions, including AI and large language models, to advance operational efficiency and innovative manufacturing practices.

Jacob Greenwood

Jacob Greenwood

Client Solutions, Northeast

Jacob Greenwood

Client Solutions, Northeast

Jake Greenwood serves as Vice President of Client Engagement for the Northeast region at Project Farma, where he leads strategic growth initiatives and client engagement efforts across the pharmaceutical and biotechnology sectors. In this role, Jake partners with clients to build long-term relationships and support programs that advance therapies from development through commercialization.

Jake brings more than 15 years of experience in the life sciences industry. He began his career in preclinical research, managing vivariums in Maryland and North Carolina, before transitioning into the Architecture, Engineering, and Construction industry, where he supported the delivery of nearly $500 million in capital projects. This combination of scientific and capital project experience enables Jake to effectively bridge early development needs with commercial manufacturing execution.

He is a past Chapter President of the ISPE Chesapeake Bay Area Chapter and remains actively engaged in the industry, with a focus on accelerating innovative therapies to market and improving patient outcomes through effective collaboration and execution.

Dan Lewis

Dan Lewis

Client Solutions

Dan Lewis

Client Solutions

Dan Lewis serves as Vice President of Client Solutions at Project Farma, where he leads strategic growth initiatives and client solution efforts across the pharmaceutical and biotechnology sectors. In this role, Dan partners with clients to build long-term relationships and support programs that advance therapies from development through commercialization.

Dan brings more than 16 years of commercial leadership experience, with a proven track record of driving revenue growth, securing new site builds, and partnering with C-suite leaders at top 25 pharmaceutical and biotechnology organizations. He has originated more than $100 million in consulting and technical operations engagements and has led sales and marketing organizations of 20–30+ professionals across highly regulated industries.

His experience includes supporting capital expansion, automation, validation, and digital transformation programs across major pharmaceutical manufacturing facilities. In addition to his consulting leadership background, Dan founded an AI-driven business strategy startup and brings strong expertise in leveraging AI-enabled targeting and analytics to accelerate market growth and inform go-to-market strategy.

Scott Hamm

Scott Hamm

Operations - Key Accounts

Scott Hamm

Operations - Key Accounts

Scott Hamm serves as Vice President of Operations – Key Accounts at Project Farma, where he drives organizational growth by staffing and delivery to account growth and new site development. In this role, Scott partners closely to guide complex programs and long-term manufacturing strategies.

Scott brings more than 30 years of experience in the life sciences industry, with deep expertise leading global capital projects and guiding cross-functional teams through planning, design, construction, commissioning, qualification, and validation. His background spans pharmaceutical and biotechnology manufacturing environments, supporting programs from early planning through operational readiness.

He has developed industry best practices and tools that have helped life sciences organizations scale efficiently and compliantly. Scott is a Project Management Professional (PMP), holds a Bachelor of Science in Electrical Engineering from Purdue University, and is an active member of the International Society for Pharmaceutical Engineering (ISPE), where he has shared his expertise through industry presentations.

Kathy Johnson

Kathy Johnson

Director, Human Resources

Kathy Johnson

Director, Human Resources

Kathy is a strategic and innovative human resources leader with more than 15 years of experience supporting organizational performance, growth, and employee engagement. In her role, she partners with leadership to translate business objectives into people strategies that strengthen culture, capability, and long-term success.

Kathy brings deep expertise in leadership coaching, talent management, and conflict resolution, with a proven ability to support managers and teams through change while improving engagement and effectiveness. She is known for her curiosity-driven leadership style and for building HR programs that align directly to business outcomes.

She holds an MBA in Human Resources from Franklin University and maintains an active Senior Professional in Human Resources (SPHR) certification.

NEWS & UPDATES

Project Farma News, Updates & Industry Insights

News

Project Farma Expands Key Offerings Through Strategic Partnership with PerkinElmer
Philanthropy

PF CARES Weekend 2025
Industry Insights

Designing Biomanufacturing Networks for the Next Wave of Therapies